Results
(130 Answers)

Answer Explanations 19

Moderate
user-995929

Mostly for prediction.

Extensive
user-377267

In my provison as chair of the CONTAM Panel of EFSA (Parma, Italy), I frequently use AI and ML in risk assessment.

Moderate
user-532952

I have as a professor been involved with HACCP and risk assessment since I returned to academia in about 1990, when computers and AI were just starting. So I still review a lot of research in One Health and Food Safety, that are aligned to risk and hazard analysis. My feeling is , when reading publications, that some authors are relying on machine generated answers , rather than logical reasoning, to estimate risks. This results in over or under estimation of risks. For instance SARS-1 was overestimated and SARS-3 underestimated in the literature.

Moderate
user-77300

Moderate

Limited
user-528003

use of (Q)SAR for predicting mutagenicity of compounds

Limited
user-125195

My experience was in managing programs to develop and apply such approaches with the goal to inform regulatory and other decisions and not to actually conduct and evaluate such studies

Moderate
user-718379

Been doing qsar for 20 years

Moderate
user-74194

I used these techniques myself, have read extensively in this area and have reviewed the work of others.

Moderate
user-598239

graph theory, nodal analysis, #D reconstruction, etc.

Extensive
user-678105

I have used numerous AI and ML programs and now consider them a waste of time.

Limited
user-441980

I am really willing to learn more in AI & ML.

Moderate
user-43697

Working with all available QSAR models (DEREK, Sarah, OECD models, previously Topkat etc)

Limited
user-542826

Experience based on reliability of ADS

None
user-483397

Non-existant at time of retirement 9 yrs ago.

Limited
user-320876

I have written an article (in press) on cancer artificial intelligent, where detailed future priorities were suggested to be focused on integration and analyses of a large body of isolated available data to identify numerous knowledge gaps on electrobiology of immune neuroplasticity in health or disease processes before giving isolated and disconnected data to AI which could complicate accurate risk assessment formulations.

Extensive
user-446741

SAB and BoD member for computational chemistry/toxicology company.

Limited
user-918734

Do some consulting in the field. Work on algorithms in the social sciences.

Limited
user-711942

I’ve had more recent experience in the last 3 years

None
user-480186

Only reading about.

Please log in to comment.